Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis Fungoides

Clinical trial NCT01645293 · UNKNOWN

Trial details

NCT number: NCT01645293
Sponsor: University of Cologne
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

CD30 Positive Cutaneous T Cell Lymphoma CD30 Positive Transformed Mycosis Fungoides

Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.